Truly INDIVIDUALIZED treatment

for EVERY round of therapy

Our vision is to TRANSFORM LIFE-THREATENING DISEASES INTO TREATABLE CONDITIONS by designing INDIVIDUALIZED therapeutics at EVERY stage of the disease.

The Aummune Therapy

The Need

Today's "personalized medicine" is based on molecular pathways and cancer cells are known to develop resistance to therapies that target a specific pathway.

The Therapy

The Aummune process is based on the company’s breakthrough therapy produced by a proprietary molecular computational process.

The Advantages

Aummune develops a tailored therapy that combats rapidly evolving diseases at every stage.

Aummune’s Mission

To improve and extend people’s lives by developing a de novo process that specifically targets the individualized disease. 

The Aummune Process

21-Day, De Novo, Personalized Therapy Development 

Tumor Sample

Tissue Processing

Evomer™ Computing

Validation

Treatment

Day 0

Day 21

End-to-End Service

Our Team

Guy Neev

CEO

Irit Carmi-Levy, PhD

CSO

Prof. Raanan Berger

CMO

Dr. Ido Bachelet

CTO

Dr. Yaniv Amir

VP R&D

Dr. Yair Schindel

Chairman

Marius Nacht

Co-Founder

© All rights reserved to Aummune | Website by Anat Belinson